EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fully modified SpyCas9 guide RNAs enable robust genome editing in cells and in vivo

Kim Anh Vu, Han Zhang, Nadia Amrani, Gitali Devi, Nicholas Gaston iD, Jonathan Lee iD, Stacy A Maitland, Zexiang Chen, Dimas Echeverria iD, Pengpeng Liu, Karthikeyan Ponnienselvan, Matthew B Hanlon und 17 weitere

Nucleic Acids Research · 10.11.2026 · 54 (21)

DOI: 10.1093/nar/gkag1105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.11.2026. Verfasst von Kim Anh Vu und 28 weiteren Autor:innen. Beteiligte Einrichtung: RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States. Hauptthemen laut MEDLINE: RNA, Guide, CRISPR-Cas Systems, CRISPR-Cas Systems, Gene Editing. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Precision engineering of CRISPR/Cas9 components has advanced genome editing toward therapeutic applications. Fully chemically modified guide RNAs (gRNAs) have the potential to improve stability and broaden therapeutic delivery strategies. However, extensive chemical modification of CRISPR guides can compromise genome editing activity by disrupting gRNA–Cas9 interactions. Here, we employed an iterative, structure-guided optimization strategy to systematically evaluate chemical modifications throughout SpyCas9 gRNAs. Extending beyond commonly used nucleotide modifications, we incorporated 2′-amino-RNA, 4′-thio-RNA, and extended nucleic acid (exNA) to generate gRNAs in which 90%–100% of nucleotides are sugar- or backbone-modified. Although the performance of individual modification patterns varied among target sequences, we established a repertoire of guides that support robust genome editing in vitro and in vivo. Collectively, these findings provide a systematic framework for rational engineering of heavily and fully modified gRNAs using diverse nucleotide chemistries for nonviral CRISPR genome editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Guide, CRISPR-Cas SystemsCRISPR-Cas SystemsGene EditingHumansAnimalsMiceHEK293 CellsBase Sequence

Substanzen

RNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • RNA Therapeutics Institute, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
  • Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
  • Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.
  • Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA 01605, United States.

ORCID-Profile: Nicholas Gaston, Jonathan Lee, Dimas Echeverria, Adam K Hedger, Ken Yamada, Julia F Alterman, Anastasia Khvorova, Scot A Wolfe, Erik J Sontheimer, Jonathan K Watts

Förderung

  • NINDS NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Vu, K. A., Zhang, H., Amrani, N., Devi, G., Gaston, N., Lee, J., Maitland, S. A., Chen, Z., Echeverria, D., Liu, P., Ponnienselvan, K., Hanlon, M. B., Lucas, C., Luk, K., Sousa, J., Cooper, D., Srnka, A., Rembetsy-Brown, J. M., Ansodaria, A. V., …, & Watts, J. K. (2026). Fully modified SpyCas9 guide RNAs enable robust genome editing in cells and in vivo. Nucleic Acids Research, 54(21). https://doi.org/10.1093/nar/gkag1105

Vancouver

Vu KA, Zhang H, Amrani N, Devi G, Gaston N, Lee J, et al. Fully modified SpyCas9 guide RNAs enable robust genome editing in cells and in vivo. Nucleic Acids Research. 2026;54(21). doi:10.1093/nar/gkag1105

BibTeX
@article{Vu2026,
  author = {Vu, Kim Anh and Zhang, Han and Amrani, Nadia and Devi, Gitali and Gaston, Nicholas and Lee, Jonathan and Maitland, Stacy A and Chen, Zexiang and Echeverria, Dimas and Liu, Pengpeng and Ponnienselvan, Karthikeyan and Hanlon, Matthew B and Lucas, Connor and Luk, Kevin and Sousa, Jacquelyn and Cooper, David and Srnka, Alyxandr and Rembetsy-Brown, Julia M and Ansodaria, Aditya Valji and Hedger, Adam K and Wagh, Atish and Bamidele, Nathan and Mir, Aamir and Yamada, Ken and Alterman, Julia F and Khvorova, Anastasia and Wolfe, Scot A and Sontheimer, Erik J and Watts, Jonathan K},
  title = {Fully modified SpyCas9 guide RNAs enable robust genome editing in cells and in vivo},
  journal = {Nucleic Acids Research},
  year = {2026},
  volume = {54},
  number = {21},
  doi = {10.1093/nar/gkag1105}
}
Kostenlos starten →